» Articles » PMID: 37168032

Orthopaedic Infections: What Have We Learned?

Overview
Journal OTA Int
Date 2023 May 11
PMID 37168032
Authors
Affiliations
Soon will be listed here.
Abstract

Orthopaedic infections remain challenging complications to treat, with profound economic impact in addition to patient morbidity. The overall estimates of infection after orthopaedic surgery with internal devices has been estimated at 5%, with hospital costs eight times that of those without fracture-related infections and with significantly poorer functional and pain interference PROMIS scores. Orthopaedic infection interventions have been focused on prevention and treatment options. The creation of new modalities for orthopaedic infection treatment can benefit from the understanding of the temporal relationship between bacterial colonization and host-cell integration, a concept referred to as "the race for the surface." Regarding prevention, host modulation and antibiotic powder use have been explored as viable options to lower infection rates. Orthopaedic infection treatment has additionally continued to evolve, with PO antibiotics demonstrating equivalent efficacy to IV antibiotics for the treatment of orthopaedic infections in recent studies. In conclusion, orthopaedic infections remain difficult clinical dilemmas, although evolving prevention and treatment modalities continue to emerge.

Citing Articles

Organisms Causing Postoperative Implant Infection in Orthopedic Patients Presenting at a Tertiary Care Hospital.

Mussab R, Khan S, Bubak S, Madni A, Ishaq U, Rimsha S Cureus. 2024; 16(10):e70821.

PMID: 39493078 PMC: 11531672. DOI: 10.7759/cureus.70821.


Circulating levels of micronutrients and risk of osteomyelitis: a Mendelian randomization study.

Zhang X, Wang J, Wu Z, Xin B, He S, He Z Front Nutr. 2024; 11:1443539.

PMID: 39416655 PMC: 11479910. DOI: 10.3389/fnut.2024.1443539.


Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application.

Ferry T, Onsea J, Roussel-Gaillard T, Batailler C, Moriarty T, Metsemakers W EFORT Open Rev. 2024; 9(5):339-348.

PMID: 38726986 PMC: 11099583. DOI: 10.1530/EOR-24-0042.


Recent Advances in Antibacterial Coatings to Combat Orthopedic Implant-Associated Infections.

Akay S, Yaghmur A Molecules. 2024; 29(5).

PMID: 38474684 PMC: 10935003. DOI: 10.3390/molecules29051172.

References
1.
Gupta D, Shah H, Malu K, Berliner N, Gaines P . Differentiation and characterization of myeloid cells. Curr Protoc Immunol. 2014; 104:22F.5.1-22F.5.28. PMC: 4539021. DOI: 10.1002/0471142735.im22f05s104. View

2.
Maier G, Horas K, Seeger J, Roth K, Kurth A, Maus U . Is there an association between periprosthetic joint infection and low vitamin D levels?. Int Orthop. 2014; 38(7):1499-504. PMC: 4071483. DOI: 10.1007/s00264-014-2338-6. View

3.
Veiseh O, Doloff J, Ma M, Vegas A, Tam H, Bader A . Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater. 2015; 14(6):643-51. PMC: 4477281. DOI: 10.1038/nmat4290. View

4.
Schrenzel J, Harbarth S, Schockmel G, Genne D, Bregenzer T, Flueckiger U . A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis. 2004; 39(9):1285-92. DOI: 10.1086/424506. View

5.
Claushuis T, van Vught L, Scicluna B, Wiewel M, Klein Klouwenberg P, Hoogendijk A . Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. 2016; 127(24):3062-72. DOI: 10.1182/blood-2015-11-680744. View